Capecitabine safety profile, innovative and generic adjuvant formulation of nonmetastatic colorectal cancer

Objective: To analyze adverse reactions in patients with nonmetastatic colorectal cancer due to treatment with either innovative or generic capecitabine and/or to the chemotherapeutic regimen employed, to the capecitabine alone, or in combination with oxaliplatin (XELOX). Method: Descriptive retrosp...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Sánchez-Gundín (Author), Ana Isabel Torres-Suárez (Author), Ana María Fernández-Carballido (Author), Dolores Barreda-Hernández (Author)
Format: Book
Published: Elsevier, 2019-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available